Skip to main content
Caplight Logo









OncoLize

OncoLize

Private
LeidenHealthcare & Life Scienceshttps://oncolize.com/

Last Round

Seed

Apr 14, 2023

Total Funding Raised

$1.7M

Company Overview

OncoLize is a biopharmaceutical company that develops injectable drug depots for localized and controlled delivery of drugs inside tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

localized drug deliveryChemoGellinjectable hydrogelslow-release drug deliverydrug delivery platformsolid tumor treatmentintratumoral injectiondrug depottargeted chemotherapydrug delivery technologyplatform licensingpancreatic cancerlung cancerdrug reformulationthermo-reversible hydrogel

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoLize Comparables

Compare OncoLize with similar companies based on industry and business-model similarity.

OncoLize comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TargTex
79%
SURGE Therapeutics
77%
PolyPid
71%

OncoLize Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 14, 2023

Key People

Founding team and executive leadership

Mike G.W. D.

Chief Executive Officer & Founder

Founding Team

OncoLize Investors

Notable investors and investment history

OncoLize investors
InvestorRounds
Libertatis Ergo HoldingSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 14, 2023

    $1.7M round led by Libertatis Ergo Holding

OncoLize Filings

Explore SEC and related filing metadata, where available.

OncoLize filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OncoLize's valuation, stock price, and market status.

Is OncoLize a public or private company?

OncoLize is a private company.

What is the current stock price of OncoLize?

OncoLize is a private company with no public stock price. No recent secondary market data is available.

How much is OncoLize worth (valuation)?

Valuation information for OncoLize is not publicly available.

Can I buy OncoLize stock?

OncoLize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OncoLize's last funding round?

Funding round information for OncoLize is not publicly available.

Who are the main investors in OncoLize?

Investor information for OncoLize is not publicly disclosed.

Will OncoLize IPO soon?

No public IPO plans have been announced for OncoLize.

How can I track OncoLize secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OncoLize's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLeiden
Employee Range5
Year Founded2017
Last FundingApr 14, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?